The AngioSculpt Scoring Balloon Catheter significantly alters the landscape for treating both peripheral arterial disease (PAD) and coronary artery disease (CAD). The innovative nitinol scoring element scores the plaque circumferentially, providing a precise and predictable dilatation across a wide range of lesion types. AngioSculpt provides the versatility and effectiveness of a new technology together with the simplicity and deliverability of a high-performance balloon catheter.

Caution: Federal law (USA) restricts the AngioSculpt Scoring Balloon Catheter to sale by or on the order of a physician.
CE Mark Granted for Coronary and Peripheral Applications.

WS-1000-0000 Rev C 03/11

February 21-23, 2013
CTO/LM Summit
New York, NY

February 23 - 26, 2013
Cardiovascular Research Technologies (CRT)
Washington, DC

February 24 - 28, 2013
ICON
Scottsdale, AZ

January 25, 2013
AngioScore Launches New 100mm Length AngioSculpt^® Scoring Balloons For Treatment of Peripheral Artery Disease Below The Knee (BTK)

October 17, 2012
AngioScore Announces Successful Initiation of Enrollment in the Valvuloplasty Scoring Balloon for Critical Aortic Valve Stenosis First-in-Human Study

July 02, 2012
AngioScore Files Patent Infringement Suit Against TriReme Medical and Quattro